Positive Results from Sophiris’ Phase 3 Trial of BPH Treatment Topsalysin Presented at Conference
News
Sophiris recently presented positive results from a Phase 3 clinical trial of its lead drug candidate topsalysin (PRX302) at the 16th Annual Needham Healthcare Conference April 4-5 in New York. The investigational ... Read more